Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Combination therapy with higher concentrations of minoxidil can lead to rapid hair growth in pattern baldness with no significant side effects.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Low-dose oral minoxidil does not increase pericardial effusions in alopecia patients.

Green tea may help relieve PCOS symptoms, but more research is needed.

Ozone bagging therapy effectively heals horse limb wounds.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Patient-reported hair improvements align with actual hair density changes, not hair width.

Patients were highly satisfied with the combined treatment of PRP and minoxidil for hair loss.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Injectable platelet-rich fibrin with microneedling is safe and effective for male hair loss but less supported than other treatments.

Surgery, especially prostatectomy, effectively reduces detrusor overactivity in bladder outlet obstruction patients.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

The new microneedle system improves hair growth in alopecia treatment.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

The new gel for psoriasis is effective, stable, and easy to apply.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.

Topical finasteride helps regrow hair and reduce balding without side effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Complex therapy is more effective for long-term control of scalp abscesses.

Tailored combination therapy improves non-scarring alopecia outcomes.

Royal Jelly gel is stable and may help with scar treatment.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.